Evidence map›Paper›PMID 31413132›Full record

ArticleJournal of virology2019

Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.

Neil Almond, Neil Berry, Richard Stebbings, Mark Preston, Claire Ham, Mark Page, Debbie Ferguson, Nicola Rose, Bo Li, Edward T Mee and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Frontiers in immunology · 2025
    Article
  2. Delivery ofFrontiers in immunology · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Neil AlmondDivision of Infectious Disease Diagnostics, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom neil.almond@nibsc.org s.patterson@imperial.ac.uk.
Neil BerryDivision of Infectious Disease Diagnostics, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Richard StebbingsBiotherapeutics Group, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Mark PrestonAnalytical Sciences Group, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Claire HamDivision of Infectious Disease Diagnostics, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Mark PageDivision of Virology, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Debbie FergusonDivision of Infectious Disease Diagnostics, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Nicola RoseDivision of Virology, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Bo LiBiotherapeutics Group, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Edward T MeeDivision of Virology, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Mark HassallDivision of Virology, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.
Christiane Stahl-HennigGerman Primate Centre, Gottingen, Germany.
Takis AthanasopoulosSchool of Biological Sciences, Royal Holloway, University of London, Surrey, United Kingdom.
Timos PapagatsiasCentre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.
Shanthi HerathCentre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.
Adel BenlahrechCentre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.
George DicksonSchool of Biological Sciences, Royal Holloway, University of London, Surrey, United Kingdom.
Andrea MeiserCentre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.
Steven PattersonCentre for Immunology and Vaccinology, Imperial College London, London, United Kingdom neil.almond@nibsc.org s.patterson@imperial.ac.uk.
National Institute for Biological Standards and Control · GBImperial College London · GBRoyal Holloway University of London · GBGerman Primate Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccines aimed at inducing T cell responses to protect against human immunodeficiency virus (HIV) infection have been under development for more than 15 years. Replication-defective adenovirus (rAd) vaccine vectors are at the forefront of this work and have been tested extensively in the simian immunodeficiency virus (SIV) challenge macaque model. Vaccination with rAd vectors coding for SIV Gag or other nonenvelope proteins induces T cell responses that control virus load but disappointingly is unsuccessful so far in preventing infection, and attention has turned to inducing antibodies to the envelope. However, here we report that Mauritian cynomolgus macaques (MCM),

Indexed as

AdenoviridaeAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDefective VirusesGene Products, gagGenetic VectorsMacaca fascicularisMaleSAIDS VaccinesSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusVaccinationVaccines, DNAViral LoadGene Products, gagSAIDS VaccinesVaccines, DNAadenovirus vectorDNA vaccinegagsimian immunodeficiency virusSIVvaccine

Identifiers

PMID31413132
PMCPMC6803269
OpenAlexW2968900875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.